Gene Clues Found In Family Epilepsy Cases

What was studied

Researchers studied 3 families with epilepsy from a highly consanguineous population. People with epilepsy had detailed clinical history, physical examination, EEG, and MRI, and their DNA was analyzed with exome sequencing.

The goal was to look for gene changes that might help explain epilepsy in these families. The researchers then used a standardized bioinformatics pipeline and ACMG guidelines to judge how likely each genetic variant was to be disease-related.

What they found

The study identified 3 different gene variants in 3 families. In one family, a homozygous KCNQ2 variant was identified in individuals with childhood-onset epilepsy and febrile seizures. In another family, a heterozygous GNAO1 variant of uncertain significance was detected in a patient with generalized tonic-clonic seizures and no developmental delay. In the third family, a homozygous LAMA5 variant classified as likely pathogenic was associated with neonatal-onset epilepsy and mesial temporal sclerosis.

Segregation analysis suggested autosomal recessive inheritance in the KCNQ2 and LAMA5 families, and autosomal dominant inheritance in the GNAO1 family. In silico predictions suggested the KCNQ2 and LAMA5 variants may have deleterious effects on protein structure and stability, while the GNAO1 change may have a milder but potentially destabilizing effect. The authors say these findings expand the mutational and phenotypic spectrum of epilepsy-associated genes in this population.

Limits of the evidence

This was a very small study of only 3 families, so it cannot show how common these variants are or establish their role in epilepsy more broadly. One of the variants, in GNAO1, was labeled a "variant of uncertain significance," which means there is not enough evidence to know if it is truly disease-related.

The study relied partly on computer predictions, which are helpful but cannot replace functional validation studies. Because the families were from a specific population, the results may not apply to all people with epilepsy.

For families and caregivers

For families, this study suggests that genetic testing such as exome sequencing may help identify a possible genetic explanation for epilepsy in some families, especially in settings where recessive inheritance may be more common. A genetic finding may sometimes help clarify inheritance patterns and support further evaluation.

At the same time, these results are preliminary and do not mean every detected variant is definitely responsible for seizures. Families may want to know that some findings are stronger than others, and uncertain results may need more research or follow-up over time.

What to watch next

Useful next steps would include larger studies and functional experiments to test how these gene changes affect protein function and their possible role in epilepsy.

Terms in this summary

exome sequencing

A genetic test that looks at the protein-coding parts of many genes at once.

consanguinity

When parents are related by blood, such as cousins.

homozygous

Having the same genetic variant in both copies of a gene.

heterozygous

Having a genetic variant in only one of the two copies of a gene.

autosomal recessive

A pattern where a person usually needs changes in both copies of a gene to be affected.

autosomal dominant

A pattern where a change in one copy of a gene can be enough to cause disease.

variant of uncertain significance

A genetic change that does not yet have enough evidence to be called harmful or harmless.

mesial temporal sclerosis

Scarring in part of the temporal lobe of the brain, which can be linked to seizures.